MedTrace Logo

Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System

NCT02262039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-01-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.

Conditions

Interventions

DEVICE

Valveless recirculating insufflation (VTI)

10 mmHg target pressure

DEVICE

Conventional pressure

15 mmHg target pressure

Sponsors & Collaborators

  • SurgiQuest, Inc.

    collaborator INDUSTRY

  • Yale University

    lead OTHER

Principal Investigators

  • Sanjay Kulkarni, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-12-31
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262039 on ClinicalTrials.gov